Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition

Biochemical and Biophysical Research Communications

Volumn 421, Issue 3, 2012, Pages 462-467

  Ji, Chao ^a   Yang, Yan Li ^a   He, Li ^b   Gu, Bing ^a   Xia, Ji Ping ^a   Sun, Wei Ling ^a   Su, Zhong Lan ^a   Chen, Bin ^a   Bi, Zhi Gang ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis and signal transduction; Ceramides; Genistein; Melanoma

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; CERAMIDE; CYTOCHROME C; GENISTEIN; HEXAMETHONIUM BROMIDE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME RELEASE; GROWTH INHIBITION; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CERAMIDES; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; GENISTEIN; HUMANS; MAP KINASE KINASE 4; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MORPHOLINES; THIAZOLES;

EID: 84860663508     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.012     Document Type: Article

References (26)

1. Syed D.N., Mukhtar H. Botanicals for the prevention and treatment of cutaneous melanoma. Pigment Cell Melanoma Res. 2011, 24:688-702.
2. Messina M.J., Persky V., Setchell K.D., et al. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 1994, 21:113-131.
3. Li D., Yee J.A., McGuire M.H., et al. Soybean isoflavones reduce experimental metastasis in mice. J. Nutr. 1999, 129:1075-1078.
4. Ji C., Yang B., Yang Y.L., et al. Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 2010, 29:6557-6568.
5. Zhu Q.Y., Wang Z., Ji C., et al. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and alpha-tubulin hyperacetylation both in vitro and in vivo. Cell. Death Dis. 2011, 2:e117.
6. Yamane M., Miyazawa K., Moriya S., et al. d,l-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells. Biochimie 2011, 93:1446-1459.
7. Yu T., Li J., Qiu Y., et al. 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation. Mol. Cell. Biochem. 2011, 361:47-54.
8. Sietsma H., Veldman R.J., Kolk D., et al. 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin. Cancer Res. 2000, 6:942-948.
9. Dijkhuis A.J., Klappe K., Jacobs S., et al. PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol. Cancer Ther. 2006, 5:593-601.
10. Le Scolan E., Pchejetski D., Banno Y., et al. Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 2005, 106:1808-1816.
11. Shida D., Takabe K., Kapitonov D., et al. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 2008, 9:662-673.
12. Ogretmen B., Hannun Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer. 2004, 4:604-616.
13. Mathias S., Pena L.A., Kolesnick R.N. Signal transduction of stress via ceramide. Biochem. J. 1998, 335(Pt 3):465-480.
14. Veldman R.J., Klappe K., Hoekstra D., et al. Metabolism and apoptotic properties of elevated ceramide in HT29 rev cells. Biochem. J. 1998, 331(Pt 2):563-569.
15. Babia T., Veldman R.J., Hoekstra D., et al. Modulation of carcinoembryonic antigen release by glucosylceramide-implications for HT29 cell differentiation. Eur. J. Biochem. 1998, 258:233-242.
16. Bose R., Verheij M., Haimovitz-Friedman A., et al. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995, 82:405-414.
17. Jaffrezou J.P., Levade T., Bettaieb A., et al. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. Embo. J. 1996, 15:2417-2424.
18. Myrick D., Blackinton D., Klostergaard J., et al. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk. Res. 1999, 23:569-578.
19. French K.J., Schrecengost R.S., Lee B.D., et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 2003, 63:5962-5969.
20. Leroux M.E., Auzenne E., Evans R., et al. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. Prostate 2007, 67:1699-1717.
21. Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell. 2005, 8:179-183.
22. Davies M.A., Stemke-Hale K., Lin E., et al. Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin. Cancer Res. 2009, 15:7538-7546.
23. Dobrowsky R.T., Kamibayashi C., Mumby M.C., et al. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 1993, 268:15523-15530.
24. Law B., Rossie S. The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide. J. Biol. Chem. 1995, 270:12808-12813.
25. Wolff R.A., Dobrowsky R.T., Bielawska A., et al. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem. 1994, 269:19605-19609.
26. Chen C.L., Lin C.F., Chang W.T., et al. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 2008, 111:4365-4374.